A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ...

A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models ...

The objective of this study—the first of its kind to treat patients with metastatic, or spreading, colorectal cancer with pretargeted radioimmunotherapy—was to improve patients' prognosis ...

Researchers at MSK, including Dr. Nai-Kong Cheung, developed the SADA technology for radioimmunotherapy, which is exclusively licensed by MSK to Y-mAbs. Dr. Cheung has intellectual property rights ...

A new alpha-radioimmunotherapy, 212Pb-anti-CD38, has proven effective in preventing tumor growth and increasing survival in multiple myeloma tumor-bearing mice, according to new research published ...

Analysis of data from patients in registration and compassionate-use trials suggests that the annualized incidences of t-MDS and t-AML are consistent with that expected in patients with NHL who have ...

The researchers hope that the experimental treatment, known as radioimmunotherapy (RIT), may be helpful in treating various infectious diseases, including HIV and cancers caused by viruses.

One such radioimmunotherapy, 90Y-clivatuzumab tetraxetan, was used in this trial: PAM4 is the antibody and yttrium-90 (90Y) is the source of radiotherapy, and they are held together by a linker.

Radioimmunotherapy Market Size Worth USD USD 81.9 Mn by 2028 Pune, Maharashtra, India, September 20 2022 (Wiredrelease) Prudour Pvt. Ltd –:In 2018, the global radioimmunotherapy market valued US$ 81.9 ...

Global Radioimmunotherapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026 recently released by MarketQuest.biz include historical and projected data for the industry, as well ...

Attaching radioactive particles to antibodies that target HIV envelope proteins resulted in clearance of more than 99% of HIV-infected cells from the spleens of immunodeficient mice, researchers from ...

New pretargeted radioimmunotherapy for colorectal cancer Date: June 6, 2011 Source: Society of Nuclear Medicine Summary: Results from a Phase 1 clinical trial for a cancer therapy show the ...